Mustgrow Biologics Corp Stock Profit Margin
| MGRO Stock | 0.80 0.04 4.76% |
MustGrow Biologics Corp fundamentals help investors to digest information that contributes to MustGrow Biologics' financial success or failures. It also enables traders to predict the movement of MustGrow Stock. The fundamental analysis module provides a way to measure MustGrow Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MustGrow Biologics stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (0.14) | (0.15) |
MustGrow | Profit Margin |
MustGrow Biologics Corp Company Profit Margin Analysis
MustGrow Biologics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current MustGrow Biologics Profit Margin | (0.14) % |
Most of MustGrow Biologics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MustGrow Biologics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MustGrow Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for MustGrow Biologics is extremely important. It helps to project a fair market value of MustGrow Stock properly, considering its historical fundamentals such as Profit Margin. Since MustGrow Biologics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MustGrow Biologics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MustGrow Biologics' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
MustGrow Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, MustGrow Biologics Corp has a Profit Margin of -0.1411%. This is 97.63% lower than that of the Chemicals sector and 92.12% lower than that of the Materials industry. The profit margin for all Canada stocks is 88.89% lower than that of the firm.
MustGrow Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MustGrow Biologics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MustGrow Biologics could also be used in its relative valuation, which is a method of valuing MustGrow Biologics by comparing valuation metrics of similar companies.MustGrow Biologics is currently under evaluation in profit margin category among its peers.
MustGrow Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0151 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 38.1 M | |||
| Shares Outstanding | 51.6 M | |||
| Shares Owned By Insiders | 10.78 % | |||
| Number Of Shares Shorted | 5.81 K | |||
| Price To Book | 22.55 X | |||
| Price To Sales | 41,750 X | |||
| Revenue | 4.71 M | |||
| Gross Profit | (190.72 K) | |||
| Book Value Per Share | 0.09 X | |||
| Short Ratio | 0.01 X | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.67 | |||
| Market Capitalization | 43.34 M |
About MustGrow Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MustGrow Biologics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MustGrow Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MustGrow Biologics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with MustGrow Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MustGrow Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MustGrow Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with MustGrow Stock
Moving against MustGrow Stock
The ability to find closely correlated positions to MustGrow Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MustGrow Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MustGrow Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MustGrow Biologics Corp to buy it.
The correlation of MustGrow Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MustGrow Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MustGrow Biologics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MustGrow Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for MustGrow Stock Analysis
When running MustGrow Biologics' price analysis, check to measure MustGrow Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MustGrow Biologics is operating at the current time. Most of MustGrow Biologics' value examination focuses on studying past and present price action to predict the probability of MustGrow Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MustGrow Biologics' price. Additionally, you may evaluate how the addition of MustGrow Biologics to your portfolios can decrease your overall portfolio volatility.